Roehrs, T., Claiborue, D., Knox, M., & Roth, T
It improves scalp health by reducing inflammation and increasing blood circulation
Altered tight junction and transporter protein levels, accumulation of -synuclein and increase in inflammatory processes lead to extravasation of blood molecules and vessel degeneration
2024;10:e37477
For researchers, this means: Published Phase 3 trial data available for reference Well-characterized safety profile from prescription use Ongoing clinical trials for additional indications (NAFLD, cognitive function) Clear differentiation from research-only peptides like BPC-157 or TB-500 For comprehensive information on FDA-approved peptides across all therapeutic categories, see our FDA Approved Peptides List 2026 guide
54 Other work confirmed the role of microglia and astrocytes in the spinal dorsal horn for the initiation and maintenance of pain sensitization during IVD degeneration